Potential anxiolytic- and antidepressant-like activity of Dipraglurant (ADX48621), the novel negative allosteric modulator (NAM) of the metabotropic glutamate 5 (mGlu5) receptor

被引:0
|
作者
Podkowa, Karolina [1 ]
Palucha-Poniewiera, Agnieszka [1 ]
Poli, Sonia [2 ]
Pilc, Andrzej [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, Krakow, Poland
[2] Addex Pharmaceut SA, CH-1228 Geneva, Switzerland
关键词
D O I
10.1016/j.pharep.2015.06.105
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:34 / 35
页数:2
相关论文
共 50 条
  • [1] The novel negative allosteric modulator (NAM) of metabotropic glutamate (mGlu5) receptor, dipraglurant, rescues electrophysiological alterations in DYT1 dystonia
    Madeo, G.
    Schirinzi, T.
    Sciamanna, G.
    Maltese, M.
    Dixon, G.
    Poli, S.
    Pisani, A.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S511 - S512
  • [2] An Open Label PET Imaging Study to Evaluate the mGlu5 Receptor Occupancy Following ADX48621 (Dipraglurant) Administration
    Wong, Dean
    Kuwabara, Hiroto
    Poli, Sonia-Maria
    Gapasin, Lorena
    Mathur, Anil
    Carenza, Elisa
    Brasic, James
    George, Noble
    Roberts, Josh
    Kitzmiller, Kelly
    Duvauchelle, Thierry
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S210 - S211
  • [3] Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist
    Tatarczynska, E
    Klodzinska, A
    Chojnacka-Wójcik, E
    Palucha, A
    Gasparini, F
    Kuhn, R
    Pilc, A
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (07) : 1423 - 1430
  • [4] On the mechanism of antidepressant-like activity of mGlu5 allosteric modulators
    Andrzej Pilc
    Agnieszka Pałucha-Poniewiera
    Piotr Brański
    Katarzyna Stachowicz
    Anna Sławińska
    Lucyna Pomierny-Chamioło
    Gabriel Nowak
    [J]. Pharmacological Reports, 2013, 65 (Suppl 1) : 22 - 23
  • [5] Preclinical Andclinical Evaluation of Dipraglurant: a Novel Negative Allosteric Modulator (NAM) of the mGlu5 Receptor for the Treatment of Dystonia and Levodopa Induced Dyskinesia
    Poli, Sonia
    [J]. CURRENT NEUROPHARMACOLOGY, 2014, 12 : 52 - 53
  • [6] Anti-parkinsonian and Anti-Dyskinetic Effects of Dipraglurant (ADX48621), a Novel mGluR5 Negative Allosteric Modulator in Clinical Development
    Poli, Sonia
    [J]. CURRENT NEUROPHARMACOLOGY, 2011, 9 : 53 - 54
  • [7] Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu4 receptor
    Slawinska, Anna
    Wieronska, Joanna M.
    Stachowicz, Katarzyna
    Palucha-Poniewiera, Agnieszka
    Uberti, Michelle A.
    Bacolod, Maria A.
    Doller, Dario
    Pilc, Andrzej
    [J]. NEUROPHARMACOLOGY, 2013, 66 : 225 - 235
  • [8] Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5)
    Varnes, Jeffrey G.
    Marcus, Andrew P.
    Mauger, Russell C.
    Throner, Scott R.
    Hoesch, Valerie
    King, Megan M.
    Wang, Xia
    Sygowski, Linda A.
    Spear, Nathan
    Gadient, Reto
    Brown, Dean G.
    Campbell, James B.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1402 - 1406
  • [9] ADX48621, a novel mGlu5 negative allosteric modulator alleviates L-DOPA-induced chorea and dystonia in the MPTP-lesioned macaque model of Parkinson's disease
    Hill, M. P.
    Girard, F.
    Keywood, C.
    Poli, S. -M.
    Crossman, A. R.
    Ravenscroft, P.
    Li, Q.
    Bezard, E.
    Mutel, V.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S281 - S282
  • [10] DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity
    Kato, Taro
    Takata, Makoto
    Kitaichi, Maiko
    Kassai, Momoe
    Inoue, Mitsuhiro
    Ishikawa, Chihiro
    Hirose, Wataru
    Yoshida, Kozo
    Shimizu, Isao
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 757 : 11 - 20